Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Walgreens Boots Alliance Inc    

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Costco says cooperating with DEA probe on controlled substances

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/17/2013 | 12:05am CEST

Costco Wholesale Corp (>> Costco Wholesale Corporation) said on Wednesday that it will cooperate with the U.S. Drug Enforcement Administration in its ongoing investigation of prescriptions for controlled substances, after receiving subpoenas and warrants from the DEA.

Costco Wholesale Corp (>> Costco Wholesale Corporation) said on Wednesday that it will cooperate with the U.S. Drug Enforcement Administration in its ongoing investigation of prescriptions for controlled substances, after receiving subpoenas and warrants from the DEA.

The DEA has targeted large pharmacy chains and distributors to stem the flow of prescription drugs where abuse is suspected.

The DEA revoked the controlled substance licenses of two CVS Caremark Corp (>> CVS Caremark Corporation) drugstores in Florida in 2012, and earlier this year Walgreen Co (>> Walgreen Company) reached a record $80 million settlement with the agency to resolve allegations that its negligence in record-keeping and dispensing allowed highly addictive drugs to reach abusers and be sold illegally.

Costco announced its plans to cooperate with the DEA's subpoenas and administrative inspection warrants in a filing with the U.S. Securities and Exchange Commission on Wednesday. It said the matter concerned its "fulfillment of prescriptions related to controlled substances and related practices."

Additional details were not provided, and company representatives declined to comment beyond what was included in the regulatory filing.

(Reporting by Jessica Wohl in Chicago; Editing by Leslie Adler and Bob Burgdorfer)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE I
04/22 WALGREENS BOOTS ALLIANCE : pays $9.8 million settlement over drug billing
04/20 WALGREENS BOOTS ALLIANCE : Declares Regular Quarterly Dividend
04/19 WALGREENS BOOTS ALLIANCE, INC. : Change in Directors or Principal Officers, Othe..
04/19 WALGREENS BOOTS ALLIANCE : José E. Almeida, Chairman and CEO of Baxter Internati..
04/18 WALGREENS : Healthcare Clinics to Offer Testing Services for Sexually Transmitte..
04/18 WALGREENS BOOTS ALLIANCE : Inspires 'Noses On' Across America to Support Third A..
04/17 WALGREENS : Inspires “Noses On” Across America to Support Third Annu..
04/14 WALGREENS BOOTS ALLIANCE : Expands Beauty Offering with Addition of NYX Professi..
04/13 WALGREENS : Expands Beauty Offering with Addition of NYX Professional Makeup Pro..
04/13 WALGREENS BOOTS ALLIANCE INC : Post Earnings Coverage as Walgreens' Quarterly Sa..
More news
Sector news : Drug Retailers - NEC
04/19DJCardinal Swoops In, Strikes Deal -- WSJ
04/18DJCARDINAL HEALTH : $6.1 Billion Deal for Some Medtronic Operations Raises Debt Co..
04/18DJCARDINAL HEALTH : $6.1 Billion Deal for Some Medtronic Operations Raises Debt Co..
03/08DJHealth Costs Get a Rethink -- WSJ
02/14DJEXPRESS SCRIPTS : Revenue Falls
More sector news : Drug Retailers - NEC
Advertisement
Financials ($)
Sales 2017 117 598 M
EBIT 2017 7 383 M
Net income 2017 4 539 M
Debt 2017 12 752 M
Yield 2017 1,80%
P/E ratio 2017 20,14
P/E ratio 2018 17,14
EV / Sales 2017 0,88x
EV / Sales 2018 0,81x
Capitalization 90 832 M
More Financials
Chart WALGREENS BOOTS ALLIANCE I
Duration : Period :
Walgreens Boots Alliance I Technical Analysis Chart | US9314221097 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 93,5 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
George Rollo Fairweather Global Chief Financial Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIAN..-0.07%90 832
WALGREENS BOOTS ALLIAN..1.53%90 832
CVS HEALTH CORP0.47%82 118
EXPRESS SCRIPTS HOLDIN..-3.39%39 897
MCKESSON CORPORATION-3.23%28 822
CARDINAL HEALTH INC0.74%22 870
More Results